| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $52.3M | +16.8% |
| R&D Expense | $109.2M | +15.7% |
| SG&A Expense | $32.0M | +11.0% |
| Operating Income | -$88.9M | -13.3% |
| Pre-tax Income | -$83.6M | -38.8% |
| Income Tax | -$5.5M | -168.7% |
| Net Income | -$78.1M | -14.4% |
| EPS (Basic) | -$2.36 | +88.2% |
| EPS (Diluted) | -$2.36 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.4M | -80.5% |
| Accounts Receivable | $1.3M | -48.7% |
| Current Assets | $258.0M | -7.3% |
| Total Assets | $324.6M | -11.0% |
| Current Liabilities | $37.3M | -45.8% |
| Total Liabilities | $89.7M | -40.0% |
| Stockholders' Equity | $234.9M | +273.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$109.1M | -19.3% |
| Capital Expenditures | $3.1M | -68.3% |
| Investing Cash Flow | -$88.2M | -292.8% |
| Financing Cash Flow | $84.0M | +8201.7% |
| Free Cash Flow | -$112.2M | -10.8% |
| +88.2% |